Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
ID: 349692Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $250K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/349692

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-240.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity through the R25 Clinical Trial Not Allowed program to enhance education on alcohol and other substance use disorders among health professionals. This initiative aims to support creative educational activities that engage practitioners in understanding current research and best practices related to the prevention, treatment, and implications of substance use disorders. The program is particularly significant in addressing the urgent need for improved awareness and treatment capabilities in public health, with grants of up to $250,000 available per year for a duration of four years. Interested applicants must submit their proposals by May 25, 2026, and can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-240.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-240-Full-Announcement.html
    PAR-23-240.html
    The National Institutes of Health (NIH) is offering funding through the R25 Education Projects to enhance education on alcohol and substance use disorders among health professionals. Focused on outreach, the program aims to disseminate current research and best practices related to prevention, treatment, and understanding of alcohol and substance use disorders. The funding opportunity encourages applications from various organizations, including higher education institutions and non-profits, with a special emphasis on promoting diversity among participants. Grants of up to $250,000 per year are available for four years, with a strong focus on projects that creatively engage practitioners in education beyond traditional training. Key components of successful applications should include comprehensive dissemination and evaluation plans, alongside strategies for enhancing diverse perspectives within the health care workforce. The review process considers the program's significance, investigator experience, innovative approaches, the clarity of educational goals, and the institutional environment's support. This grant program responds to the urgent need for improved awareness and treatment capabilities surrounding substance use disorders, thereby contributing to public health efforts.
    Similar Opportunities
    Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)." This initiative aims to support educational activities that promote diversity in the biomedical and behavioral sciences, particularly focusing on substance use and addiction research, by encouraging applications from institutions committed to underrepresented groups. The program seeks to develop a diverse pool of researchers through mentorship and educational activities tailored to various career stages, with a budget request limit of $250,000 in direct costs annually for up to five years. Interested applicants must submit their proposals by 5:00 PM local time on November 13, 2026, and can direct inquiries to grantsinfo@nih.gov for further information.
    NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Research Education Program for Clinical Researchers and Clinicians under Funding Opportunity Number PAR-25-204, aimed at enhancing the training of clinicians and clinical researchers in substance use disorder (SUD) research. This program seeks to address the shortage of qualified professionals in the field by supporting educational activities that develop skills and provide hands-on research experiences, particularly targeting underrepresented groups in the workforce. With a budget of up to $350,000 annually for a project duration not exceeding five years, the program is open for applications starting February 11, 2025. Interested applicants can find more information and guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)" aimed at advancing research in the treatment and recovery from alcohol use disorder (AUD). This grant supports clinical trials focusing on various aspects of AUD, including medication development, behavioral therapies, and innovative treatment technologies, particularly for populations facing health disparities. The funding is crucial for enhancing the understanding and efficacy of AUD treatments, ultimately contributing to improved public health outcomes. Eligible applicants can receive up to $500,000 in direct costs over a maximum project period of five years, with key submission deadlines on October 5, 2023, and February 5, 2024. For more information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-250.html.
    Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Alcohol Treatment, Pharmacotherapy, and Recovery Research grant, specifically under the R01 Clinical Trial Required mechanism. This funding opportunity aims to advance research on Alcohol Use Disorder (AUD) by focusing on various aspects such as medication development, behavioral therapies, recovery mechanisms, and innovative treatment technologies. The NIH emphasizes the importance of addressing AUD, particularly for underserved populations, and seeks projects that translate neuroscience research into practical applications. Interested applicants can apply for a grant with an award ceiling of $500,000, with the application process opening on January 5, 2025, and submissions due by September 7, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PA-25-163.html.
    Alcohol Health Services Research (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for the Alcohol Health Services Research (R01 Clinical Trial Optional) grant. This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on five key areas: increasing access to treatment, enhancing the appeal of treatment, examining cost structures and insurance systems, studying the dissemination and implementation of evidence-based approaches, and reducing health disparities among affected populations. The grant allows for a maximum budget of $500,000 and a project period of up to five years, with applications due by September 7, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)" aimed at supporting research into effective interventions for substance use disorders (SUDs) and overdose. This cooperative agreement encourages applications for preclinical and clinical studies focusing on pharmacotherapies, device-based treatments, digital therapeutics, and behavioral interventions, with the goal of advancing these interventions towards regulatory approval or clinical adoption. The funding amount can reach up to $3 million, and applications are due by 5:00 PM local time, with multiple submission cycles from October 2025 to August 2028. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Substance Use/Substance Use Disorder Dissertation Research Award (R36), aimed at supporting doctoral candidates for up to two years in their dissertation research related to substance use disorders. This grant, under the National Institute on Drug Abuse (NIDA), encourages applications from diverse backgrounds and focuses on advancing knowledge in prevention, diagnosis, and treatment of substance misuse and related health outcomes, excluding independent clinical trials. Eligible applicants can receive up to $50,000 per year for innovative research aligned with NIDA’s strategic plan, with applications due by September 7, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) to support institutional research career development programs aimed at clinician scientists. This grant is designed to provide intensive supervised research training and career development experiences, ultimately leading to research independence in the field of substance use and substance use disorders. The program encourages applications focusing on various scientific areas, including neuroimaging, genetics, medication development, and implementation science, among others. Interested applicants from private institutions of higher education should prepare for the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis post date of July 3, 2025, and a close date of August 5, 2025. For further inquiries, applicants can contact Lindsey Friend, Ph.D., at NIDA via email at NIDATraining@nida.nih.gov or by phone at 301-402-1428.
    Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders" (R34 Clinical Trial Optional). This initiative encourages pilot studies aimed at preparing for larger-scale effectiveness trials that focus on optimizing access, quality, and affordability of substance use disorder treatments and related services, with an emphasis on diverse perspectives through a Plan for Enhancing Diverse Perspectives (PEDP). Applicants may request up to $450,000 in direct costs for a three-year grant, with application due dates beginning January 16, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-100.html.
    Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)" to support doctoral candidates in completing their dissertation research projects related to substance use disorders. This funding initiative aims to enhance the pool of talented researchers in the field by providing grants of up to $50,000 per year for direct costs over a maximum of two years, with a focus on projects that align with the National Institute on Drug Abuse (NIDA) strategic priorities. Applications are particularly encouraged from individuals who can contribute to diversifying the research workforce, and interested candidates must submit their applications by October 16, 2023, or on February 16 and June 16, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.